Bringing the fundamentals into focus…
Back to West Pharmaceutical Services, Inc.
How West Pharmaceutical Services, Inc. stacks up
WST · against 88 other Healthcare companies of similar size
Profitability
91/ 100
Near the top of its peers.
Ranked #22 of 89 · scores higher than 75% of peers
Bars: peers in each 10-point band of the profitability score26 peers with a profitability score of 90–100, including WST · Click a bar to see the companies
Why profitability scores 91?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its return on assets, return on invested capital and operating margin, which are stronger than most Healthcare peers.
- a wider operating margin: stronger than 81% of peers. Operating margin: 20.5% vs peer median 7.1%
- a higher return on invested capital: stronger than 85% of peers. Return on invested capital: 19.5% vs peer median 4.7%
- a higher return on assets: stronger than 94% of peers. Return on assets: 13.9% vs peer median 1.7%
Metric by metric
Position: dot = WST, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | WST | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 86 reported | 19.5% | 12.7% | 69% | 33% | |
| Operating marginHigher is better · 87 reported | 20.5% | 19.3% | 55% | 33% | |
| Return on assetsHigher is better · 84 reported | 13.9% | 6.9% | 81% | 33% | |
| Return on equityHigher is better · 80 reported | 19.1% | 13.7% | 67% | Context only | |
| Gross marginHigher is better · 89 reported | 36.8% | 59.8% | 19% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around WST| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 13.9B EUR (≈$15.3B) | 99 | 78 | |
| 4 | 8.24T JPY (≈$56.0B) | 98 | 75 | |
| 4 | 23.8B USD | 98 | 84 | |
| 18 | 56.7B USD | 93 | 79 | |
| 18 | 2.67T INR (≈$32.1B) | 93 | 68 | |
| 18 | 40.2B USD | 93 | 73 | |
| 22 | 16.8B USD | 91 | 75 | |
| 22 | 28.6B USD | 91 | 60 | |
| 24 | 16.1B CHF (≈$18.5B) | 90 | 54 | |
| 24 | 21.5B USD | 90 | 60 | |
| 24 | 49.1B USD | 90 | 69 | |
| 27 | 111.7B DKK (≈$16.8B) | 89 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score